Follow

Lipum AB company presentation and Q&A at the BioStock Life Science Summit 2020

28 January 2021 - 08:40
Nasdaq First North GM Stockholm (Sweden)
Lipum AB
Lipum is a biopharmaceutical company. It specializes in the discovery and development of new treatment for chronic inflammatory diseases. The drug candidate SOL-116 is a humanized antibody that aims to provide safer and more effective treatment by blocking a previously overlooked target molecule (BSSL) in the immune system....
Learn more about company

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More